Luís M. A. Oliveira
- Neurology top 2%
- Parkinson's Disease Mechanisms and Treatments 8
- Neurological disorders and treatments 3
- Botulinum Toxin and Related Neurological Disorders 2
- Clinical Biochemistry top 2%
- Advanced Glycation End Products research 3
-
- Nuclear Receptors and Signaling 3
- Nerve injury and regeneration 2
- Neurology top 10%
- Parkinson's Disease Mechanisms and Treatments 8
- Neurological disorders and treatments 3
- Botulinum Toxin and Related Neurological Disorders 2
- Physiology top 10%
- Alzheimer's disease research and treatments 5
-
- Gold and Silver Nanoparticles Synthesis and Applications 1
- Co-authors
- Alexandre QuintasTiago F. OuteiroThomas M. JovinAna Varela CoelhoRicardo A. GomesPaul LingorCarlos FamíliaJan Christoph Koch
- Journals
- Cell Death and Disease (2 papers)PLoS ONE (2 papers)Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics (1 paper)
- Partner nations
- PortugalUnited StatesGermany
In The Last Decade
Luís M. A. Oliveira
13 papers receiving 921 citations
Peers
Comparison fields: 5 of 82
- Neurology 520
- Clinical Biochemistry 153
- Cellular and Molecular Neuroscience 328
- Neurology 93
- Physiology 278
Countries citing papers authored by Luís M. A. Oliveira
This map shows the geographic impact of Luís M. A. Oliveira's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luís M. A. Oliveira with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luís M. A. Oliveira more than expected).
Fields of papers citing papers by Luís M. A. Oliveira
This network shows the impact of papers produced by Luís M. A. Oliveira. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luís M. A. Oliveira. The network helps show where Luís M. A. Oliveira may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Luís M. A. Oliveira, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 23 | |
| 2 | 2021 | 96 | |
| 3 | 2017 | 19 | |
| 4 | 2015 | 123 | |
| 5 | 2015 | 107 | |
| 6 | 2014 | 69 | |
| 7 | 2012 | 219 | |
| 8 | 2012 | 49 | |
| 9 | 2011 | 92 | |
| 10 | 2009 | 56 | |
| 11 | 2008 | 29 | |
| 12 | 2008 | 47 | |
| 13 | 2007 | 2 |
About Luís M. A. Oliveira
Luís M. A. Oliveira is a scholar working on Neurology, Clinical Biochemistry and Cellular and Molecular Neuroscience, having authored 13 papers that have together received 931 indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (8 papers), Alzheimer's disease research and treatments (5 papers), Nuclear Receptors and Signaling (3 papers), Neurological disorders and treatments (3 papers), Advanced Glycation End Products research (3 papers), Botulinum Toxin and Related Neurological Disorders (2 papers), Nerve injury and regeneration (2 papers) and Gold and Silver Nanoparticles Synthesis and Applications (1 paper). The work is most often cited by research in Neurology (520 citations), Clinical Biochemistry (153 citations) and Cellular and Molecular Neuroscience (328 citations). Luís M. A. Oliveira has collaborated with scholars based in Portugal, United States and Germany. Frequent co-authors include Alexandre Quintas, Tiago F. Outeiro, Thomas M. Jovin, Ana Varela Coelho, Ricardo A. Gomes, Paul Lingor, Carlos Família, Jan Christoph Koch, Lisandro J. Falomir‐Lockhart and Birgitt Schüle. Their work appears in journals such as Cell Death and Disease, PLoS ONE, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, Journal of Neuroscience and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.